PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 2.92M (Avg.)
-0.48 | -4.19
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
39707.24%
G&A change of 39707.24% versus flat Healthcare overhead. Walter Schloss would verify efficiency.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
42213.03%
Operating expenses growth exceeding 1.5x Healthcare median of 0.31%. Jim Chanos would check for waste.
39675.25%
Total costs growth exceeding 1.5x Healthcare median of 0.69%. Jim Chanos would check for waste.
15324.18%
Interest expense change of 15324.18% versus flat Healthcare costs. Walter Schloss would verify control.
No Data
No Data available this quarter, please select a different quarter.
-37386.56%
EBITDA decline while Healthcare median is 1.78%. Seth Klarman would investigate causes.
No Data
No Data available this quarter, please select a different quarter.
-5650.01%
Operating income decline while Healthcare median is 0.86%. Seth Klarman would investigate causes.
No Data
No Data available this quarter, please select a different quarter.
-570772.46%
Other expenses reduction while Healthcare median is 0.00%. Seth Klarman would investigate advantages.
-40472.45%
Pre-tax income decline while Healthcare median is 1.57%. Seth Klarman would investigate causes.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-40472.45%
Net income decline while Healthcare median is 3.39%. Seth Klarman would investigate causes.
No Data
No Data available this quarter, please select a different quarter.
-3050.00%
EPS decline while Healthcare median is 6.43%. Seth Klarman would investigate causes.
-3050.00%
Diluted EPS decline while Healthcare median is 6.22%. Seth Klarman would investigate causes.
1209.23%
Share count reduction below 50% of Healthcare median of 0.12%. Jim Chanos would check for issues.
1209.23%
Diluted share reduction below 50% of Healthcare median of 0.12%. Jim Chanos would check for issues.